Reassessing Nutanix (NTNX) Valuation After Recent Share Price Volatility Today at 01:11 (Time of New York)

How TP-05’s Phase 2 Lyme Prophylaxis Trial Progress Could Impact Tarsus Pharmaceuticals (TARS) Investors Today at 01:10 (Time of New York)

How The ThredUp (TDUP) Investment Narrative Is Shifting With Resale Growth And Lower Targets Today at 01:10 (Time of New York)

Citigroup (C) Valuation In Focus As Long Term Returns Contrast With Recent Share Performance Today at 01:09 (Time of New York)

Tripadvisor Governance Shift With Starboard Sparks Questions On Valuation And Risks Today at 01:09 (Time of New York)